Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies
Clinical trial NCT03637764 · TERMINATED
Trial details
- NCT number
- NCT03637764
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-06
- Primary completion
- 2022-05-11
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.